Semaglutide can help the body make more insulin and improves insulin sensitivity, which in turn lowers blood-glucose levels ...

Learn about semaglutide’s effectiveness and clinical trial results and whether it could be right for you in your MASH ...

The survey showed that while most of the doctors didn’t have top-of-mind awareness of oral semaglutide’s upcoming FDA ...

Real-world data show semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) are linked with lower risk of major ...

The MarketWatch News Department was not involved in the creation of this content.-- Wegovy(R) (semaglutide injection) granted conditional marketing authorization for the treatment ...

The meta-analysis identified a significant association between treatment with semaglutide and risk for NAION (OR, 3.92; 95% CI, 1.02-15.02). Of five trials reporting NAION, incidence reached 60.7 per ...

A peripherally acting cannabinoid receptor 1 antibody combined with semaglutide induced significant weight loss for adults ...

Shortly after, Novo Nordisk's CEO Mike Doustdar signaled the company is "all in" on the forthcoming launch of oral semaglutide, emphasizing robust supply readiness ahead of the anticipated year-end ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. What Happens If You Use Expired Semaglutide? Wondering what ...

Certain compounded forms of semaglutide may not contain the same active ingredient as the approved versions for type 2 diabetes and weight-loss, the FDA warned earlier this week. These salt forms of ...

Research isn’t clear on whether semaglutide causes thyroid tumors. But people with a history of thyroid cancer may want to avoid using this diabetes and weight loss medication. Semaglutide is in a ...

Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most ...